ID   ZN567_HUMAN             Reviewed;         647 AA.
AC   Q8N184; B3KX49; Q6N044;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 3.
DT   28-JUN-2023, entry version 176.
DE   RecName: Full=Zinc finger protein 567;
GN   Name=ZNF567;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Prostate;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-173, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-173; LYS-202; LYS-217; LYS-233
RP   AND LYS-447, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       Q8N184; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-749400, EBI-10175124;
CC       Q8N184; Q9NYL2: MAP3K20; NbExp=3; IntAct=EBI-749400, EBI-602273;
CC       Q8N184; Q9NYL2-2: MAP3K20; NbExp=7; IntAct=EBI-749400, EBI-10255081;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=Q8N184-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q8N184-1; Sequence=VSP_016383;
CC       Name=2;
CC         IsoId=Q8N184-2; Sequence=VSP_016384;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK126691; BAG54361.1; -; mRNA.
DR   EMBL; BX640706; CAE45826.1; -; mRNA.
DR   EMBL; BC033849; AAH33849.2; -; mRNA.
DR   CCDS; CCDS12495.1; -. [Q8N184-1]
DR   CCDS; CCDS74349.1; -. [Q8N184-3]
DR   RefSeq; NP_001287908.1; NM_001300979.1. [Q8N184-3]
DR   RefSeq; NP_001309840.1; NM_001322911.1. [Q8N184-1]
DR   RefSeq; NP_001309841.1; NM_001322912.1. [Q8N184-1]
DR   RefSeq; NP_001309842.1; NM_001322913.1. [Q8N184-3]
DR   RefSeq; NP_001309843.1; NM_001322914.1. [Q8N184-3]
DR   RefSeq; NP_001309844.1; NM_001322915.1. [Q8N184-3]
DR   RefSeq; NP_001309845.1; NM_001322916.1. [Q8N184-3]
DR   RefSeq; NP_001309846.1; NM_001322917.1. [Q8N184-3]
DR   RefSeq; NP_001309847.1; NM_001322918.1. [Q8N184-3]
DR   RefSeq; NP_001309848.1; NM_001322919.1. [Q8N184-3]
DR   RefSeq; NP_001309849.1; NM_001322920.1. [Q8N184-3]
DR   RefSeq; NP_689816.2; NM_152603.4. [Q8N184-1]
DR   RefSeq; XP_011524886.1; XM_011526584.2.
DR   RefSeq; XP_016881906.1; XM_017026417.1.
DR   RefSeq; XP_016881907.1; XM_017026418.1.
DR   RefSeq; XP_016881909.1; XM_017026420.1.
DR   RefSeq; XP_016881910.1; XM_017026421.1.
DR   AlphaFoldDB; Q8N184; -.
DR   SMR; Q8N184; -.
DR   BioGRID; 127848; 10.
DR   IntAct; Q8N184; 5.
DR   MINT; Q8N184; -.
DR   STRING; 9606.ENSP00000441838; -.
DR   GlyGen; Q8N184; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8N184; -.
DR   PhosphoSitePlus; Q8N184; -.
DR   BioMuta; ZNF567; -.
DR   DMDM; 150387826; -.
DR   jPOST; Q8N184; -.
DR   MassIVE; Q8N184; -.
DR   MaxQB; Q8N184; -.
DR   PaxDb; Q8N184; -.
DR   PeptideAtlas; Q8N184; -.
DR   ProteomicsDB; 71570; -. [Q8N184-3]
DR   ProteomicsDB; 71571; -. [Q8N184-1]
DR   ProteomicsDB; 71572; -. [Q8N184-2]
DR   Antibodypedia; 16328; 62 antibodies from 13 providers.
DR   DNASU; 163081; -.
DR   Ensembl; ENST00000360729.8; ENSP00000353957.3; ENSG00000189042.14. [Q8N184-1]
DR   Ensembl; ENST00000536254.6; ENSP00000441838.1; ENSG00000189042.14. [Q8N184-3]
DR   Ensembl; ENST00000585696.5; ENSP00000467379.1; ENSG00000189042.14. [Q8N184-1]
DR   Ensembl; ENST00000682579.1; ENSP00000507048.1; ENSG00000189042.14. [Q8N184-3]
DR   GeneID; 163081; -.
DR   KEGG; hsa:163081; -.
DR   MANE-Select; ENST00000682579.1; ENSP00000507048.1; NM_001322917.1; NP_001309846.1.
DR   UCSC; uc002oep.5; human. [Q8N184-3]
DR   AGR; HGNC:28696; -.
DR   CTD; 163081; -.
DR   GeneCards; ZNF567; -.
DR   HGNC; HGNC:28696; ZNF567.
DR   HPA; ENSG00000189042; Low tissue specificity.
DR   neXtProt; NX_Q8N184; -.
DR   OpenTargets; ENSG00000189042; -.
DR   PharmGKB; PA134986394; -.
DR   VEuPathDB; HostDB:ENSG00000189042; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000162697; -.
DR   HOGENOM; CLU_002678_17_1_1; -.
DR   InParanoid; Q8N184; -.
DR   OMA; CNGYGKS; -.
DR   PhylomeDB; Q8N184; -.
DR   TreeFam; TF337898; -.
DR   PathwayCommons; Q8N184; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   SignaLink; Q8N184; -.
DR   BioGRID-ORCS; 163081; 13 hits in 1182 CRISPR screens.
DR   ChiTaRS; ZNF567; human.
DR   GenomeRNAi; 163081; -.
DR   Pharos; Q8N184; Tdark.
DR   PRO; PR:Q8N184; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8N184; protein.
DR   Bgee; ENSG00000189042; Expressed in endothelial cell and 168 other tissues.
DR   ExpressionAtlas; Q8N184; baseline and differential.
DR   Genevisible; Q8N184; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 14.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24381; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24381:SF360; ZINC FINGER PROTEIN 567; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 13.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 14.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 9.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 14.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 15.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..647
FT                   /note="Zinc finger protein 567"
FT                   /id="PRO_0000047658"
FT   DOMAIN          6..77
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         210..232
FT                   /note="C2H2-type 1; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         253..275
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         281..303
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         309..331
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         337..359
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         365..387
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         393..415
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         421..443
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         449..471
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         477..499
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         505..527
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         533..555
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         561..583
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         589..611
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         617..639
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   CROSSLNK        173
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        217
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        233
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        447
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..31
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016383"
FT   VAR_SEQ         579..634
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_016384"
FT   CONFLICT        59
FT                   /note="E -> G (in Ref. 2; CAE45826)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   647 AA;  75164 MW;  0A384AF156FA2B78 CRC64;
     MAQGSVSFND VTVDFTQEEW QHLDHAQKTL YMDVMLENYC HLISVGCHMT KPDVILKLER
     GEEPWTSFAG HTCLEENWKA EDFLVKFKEH QEKYSRSVVS INHKKLVKEK SKIYEKTFTL
     GKNPVNSKNL PPEYDTHGRI LKNVSELIIS NLNPARKRLS EYNGYGKSLL STKQETTHPE
     VKSHNQSARA FSHNEVLMQY QKTETPAQSF GYNDCEKSFL QRGGLITHSR PYKGENPSVY
     NKKRRATNIE KKHTCNECGK SFCRKSVLIL HQGIHSEEKP YQCHQCGNAF RRKSYLIDHQ
     RTHTGEKPFV CNECGKSFRL KTALTDHQRT HTGEKSYECL QCRNAFRLKS HLIRHQRTHT
     GEKPYECNDC GKSFRQKTTL SLHQRIHTGE KPYICKECGK SFHQKANLTV HQRTHTGEKP
     YICNECGKSF SQKTTLALHE KTHNEEKPYI CSECGKSFRQ KTTLVAHQRT HTGEKSYECP
     HCGKAFRMKS YLIDHHRTHT GEKPYECNEC GKSFSQKTNL NLHQRIHTGE KPYVCNECGK
     SFRQKATLTV HQKIHTGQKS YECPQCGKAF SRKSYLIHHQ RTHTGEKPYK CSECGKCFRQ
     KTNLIVHQRT HTGEKPYVCN ECGKSFSYKR NLIVHQRTHK GENIEMQ
//
